2 results
Approved WMOCompleted
Primary Objective:To assess the efficacy potential of GSK3196165 on pain in inflammatory HOA.Secondary endpoints:To evaluate impact of GSK3196165 on average and worst HOA pain, over time.To assess the impact of GSK3196165 on hand pain (on use),…
Not approvedWill not start
Assess cognitive efficacy of gantenerumab, solanezumab in individuals who have mutations causing dominantly inherited Alzheimer's disease as measured by change in the DIAN-TU cognitive composite score between baseline and a minimum of 4 years.…